Advertisement
Advertisement
ZTS
ZOETIS INC.
121.70
USDSponsored
+3.55
+3.00%
Mar 17, 16:00 UTC -4
Closed
After-Market
121.75
+0.05
+0.05%
ZTS Earnings Reports
Positive Surprise Ratio
ZTS beat 35 of 40 last estimates.
88%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.33B
/$1.62
Implied change from Q4 25 (Revenue/ EPS)
-2.37%
/+9.46%
Implied change from Q1 25 (Revenue/ EPS)
+4.97%
/+9.46%
ZOETIS INC. earnings per share and revenue
On Feb 12, 2026, ZTS reported earnings of 1.48 USD per share (EPS) for Q4 25, beating the estimate of 1.41 USD, resulting in a 4.53% surprise. Revenue reached 2.39 billion, compared to an expected 2.38 billion, with a 0.14% difference. The market reacted with a -2.35% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 13 analysts forecast an EPS of 1.62 USD, with revenue projected to reach 2.33 billion USD, implying an increase of 9.46% EPS, and decrease of -2.37% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Guardian Pharmacy Services, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.25
Actual
$0.33
Surprise
+29.41%
Oruka Therapeutics, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.64
Actual
-$0.45
Surprise
+29.69%
Savara Inc.
Report Date
Mar 13, 2026 For Q4 25
Estimate
-$0.12
Actual
-$0.13
Surprise
-8.15%
Nektar Therapeutics
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$2.52
Actual
-$1.78
Surprise
+29.47%
Lyell Immunopharma, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$2.27
Actual
-$7.50
Surprise
-229.53%
Minerva Neurosciences, Inc
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$0.30
Actual
-$0.64
Surprise
-109.15%
Tonix Pharmaceuticals Holding Corp.
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$3.25
Actual
-$3.98
Surprise
-22.32%
Century Therapeutics, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.28
Actual
-$0.22
Surprise
+23.88%
Korro Bio, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$2.10
Actual
-$1.65
Surprise
+21.74%
Champions Oncology, Inc.
Report Date
Mar 12, 2026 For Q3 26
Estimate
$0.09
Actual
-$0.02
Surprise
-121.79%
FAQ
What were ZOETIS INC.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, ZOETIS INC. reported EPS of $1.48, beating estimates by 4.53%, and revenue of $2.39B, 0.14% above expectations.
How did the market react to ZOETIS INC.'s Q4 2025 earnings?
The stock price moved down -2.35%, changed from $128.67 before the earnings release to $125.64 the day after.
When is ZOETIS INC. expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for ZOETIS INC.'s next earnings report?
Based on 13
analysts, ZOETIS INC. is expected to report EPS of $1.62 and revenue of $2.33B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement